Avai Bio (AVAI) Debt to Equity (2018 - 2023)
Avai Bio's Debt to Equity history spans 6 years, with the latest figure at -$0.07 for Q4 2023.
- On a quarterly basis, Debt to Equity rose 82.4% to -$0.07 in Q4 2023 year-over-year; TTM through Dec 2023 was -$0.07, a 82.4% increase, with the full-year FY2023 number at -$0.31, down 28.09% from a year prior.
- Debt to Equity hit -$0.07 in Q4 2023 for Avai Bio, up from -$0.1 in the prior quarter.
- Over the last five years, Debt to Equity for AVAI hit a ceiling of $0.09 in Q3 2020 and a floor of -$1.53 in Q3 2019.
- Historically, Debt to Equity has averaged -$0.31 across 5 years, with a median of -$0.1 in 2023.
- Biggest five-year swings in Debt to Equity: surged 105.98% in 2020 and later crashed 1054.8% in 2022.
- Tracing AVAI's Debt to Equity over 5 years: stood at -$1.53 in 2019, then skyrocketed by 94.29% to -$0.09 in 2020, then surged by 75.76% to -$0.02 in 2021, then tumbled by 1799.96% to -$0.4 in 2022, then skyrocketed by 82.4% to -$0.07 in 2023.
- Business Quant data shows Debt to Equity for AVAI at -$0.07 in Q4 2023, -$0.1 in Q3 2023, and -$0.1 in Q2 2023.